Welcome to our dedicated page for Rubicon Organics news (Ticker: ROMJF), a resource for investors and traders seeking the latest updates and insights on Rubicon Organics stock.
Rubicon Organics Inc. (ROMJF) operates at the forefront of Canada's premium cannabis market, specializing in organic cultivation and innovative product development. This news hub provides investors and industry professionals with essential updates about the company's strategic initiatives, regulatory compliance, and market positioning.
Access consolidated coverage of operational milestones including cultivation advancements, product line expansions, and financial performance. Our repository ensures efficient tracking of Rubicon Organics' progress in key areas such as quality-focused production, supply chain optimization, and brand portfolio management.
Key updates include earnings reports, regulatory filings, partnership announcements, and product innovation launches. Each news item is curated to reflect the company's commitment to operational excellence in the competitive cannabis sector.
Bookmark this page for streamlined access to Rubicon Organics' official communications and third-party analyses. Regularly updated content supports informed decision-making for stakeholders monitoring the evolving cannabis industry landscape.
Rubicon Organics (ROMJF) has cleared all conditions precedent for acquiring the Hope Facility from Medipharm Labs Inc. The facility is a 47,500 square foot indoor cultivation facility located in Hope, British Columbia. This strategic acquisition is expected to significantly expand Rubicon's premium cannabis production capacity.
The company, which specializes in organic certified and premium cannabis products, anticipates closing the acquisition in the second quarter. CEO Margaret Brodie emphasized that this acquisition represents a pivotal step in meeting growing demand for their premium brands, accelerating innovation, and creating long-term shareholder value.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has scheduled its Q1 2025 financial results announcement for Tuesday, May 27, 2025, after market close.
The company will host a conference call to discuss the results on Wednesday, May 28, 2025, at 7:00 AM PT / 10:00 AM ET. Investors can join via local dial-in (+1 (289) 514 5100) or toll-free North America (+1 (800) 717 1738) using conference ID 34244.
Rubicon Organics (ROMJF) has appointed Glen Ibbott, former CFO of Aurora Cannabis, as its Interim Chief Financial Officer, effective May 15, 2025. Ibbott replaces Janis Risbin, who will transition to an advisory role. With over 25 years of leadership experience in publicly-traded companies, Ibbott is known for his significant role at Aurora Cannabis (2017-2024), where he drove rapid growth and achieved positive EBITDA. His experience includes senior finance roles at healthcare companies and a crucial role in QLT Inc.'s $500 million merger with Aegerion Pharmaceuticals.
Ibbott, who holds dual CPA designations and MBAs from Cornell and Queen's University, joins Rubicon as the company plans to scale new capacity and explore international markets. The company has initiated a search for a permanent CFO, considering both internal and external candidates.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), Canada's leading premium licensed cannabis producer, has announced its participation in two major industry events in April 2025:
1. Planet MicroCap Showcase: VEGAS 2025 (April 22-24):
- Company presentation on April 23 at 11:30 AM PST
- One-on-one investor meetings with CEO Margaret Brodie on April 24
- Location: Paris Hotel & Casino, Las Vegas
2. ICBC Berlin B2B (April 29-30):
- CEO Margaret Brodie to participate in panel discussion on April 29 at 11:45 AM CET
- Panel focuses on future of cannabis B2B ecosystem
- Location: Estrel Berlin Hotel, Berlin, Germany
Rubicon Organics (ROMJF) reported strong financial results for 2024, with record-high net revenue of $48.7 million, representing a 21% increase from 2023. The company achieved an Adjusted EBITDA of $4.0 million and operating cash flow of $3.4 million.
Q4 2024 highlights include net revenue of $14.2 million (up 42% from Q4 2023), Adjusted EBITDA of $1.6 million, and positive operating cashflows of $2.3 million. The company secured $10 million in credit facilities at 6.75% interest for 5 years and entered into a purchase agreement for a Hope, BC facility that will expand premium flower capacity by 40%.
Key market positions include: 27.1% market share in topicals, 2.0% in national flower and pre-rolls, and 26.5% in premium edibles. The company's vape launch achieved 13.4% national market share with 56% distribution within six months.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has announced its upcoming financial results release schedule. The company will report its Q4 2024 and full-year results for the period ended December 31, 2024, after market close on Tuesday, April 1, 2025. A conference call to discuss the results is scheduled for Wednesday, April 2, 2025.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has achieved a significant milestone with its first international shipment of premium dried flower to Poland. The company, known for organic certified premium cannabis products, is expanding its reach into the European market, specifically Poland, which has over 90,000 medical cannabis patients.
The company is strengthening its production capabilities through a planned acquisition of a facility in Hope, BC, which will add 4,500 kgs of annual production capacity. This expansion aims to meet both international market demands and unfilled needs in the Canadian market.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), Canada's leading premium cannabis producer, announces participation in two major industry events in March 2025.
The company will present at the Ventum Canadian Cannabis Conference on March 12th, where CEO Margaret Brodie will discuss financial performance and expansion plans during a 20-minute presentation at 2:40 PM EST. Rubicon was selected among top-performing companies showing profitable growth despite market challenges.
Additionally, Rubicon will attend the Global Cannabis Regulatory Summit in Washington, D.C. from March 25-27th. Hosted by Artemis Growth Partners at the U.S. Capitol Complex, this summit will unite international regulators, policymakers, and industry leaders from over a dozen countries to shape global cannabis policies and foster international partnerships.